Background—Angiogenesis is a promising treatment strategy for patients who are not candidates
for standard revascularization, because it promotes the growth of new blood vessels in …

Coronary occlusive disease is the leading cause of death in industrial nations and affects
one in four adults. Although heart attacks are caused by occlusion of a coronary artery, some …

Objective— To assess the importance of genetic background for collateral artery development.
Methods and Results— C57BL/6, BALB/c and 129S2/Sv mice were studied after femoral …

Objective: Previous investigations have shown the effectiveness of sustained intra- or
extravascular administration of vascular endothelial growth factor (VEGF) in chronic myocardial …

Background. Patients not amenable to complete myocardial revascularization by conventional
methods present a difficult clinical problem. Here we present the early results and …

OBJECTIVES Evaluate the safety, tolerability and preliminary efficacy of intracoronary (IC)
basic fibroblast growth factor (bFGF, FGF-2). BACKGROUND FGF-2 is a heparin-binding …

Objectives : The purpose of this study was to examine the effect of exercise-induced
ischemia on levels of B-type natriuretic peptide (BNP) and its inactive N-terminal fragment (NT-pro-…

The purpose of our study was threefold: to evaluate the ability of excretory phase CT urography
to opacify the urinary collecting system by comparing opacification seen on CT with the …

Therapeutic angiogenesis is a novel approach to the treatment of myocardial ischemia based
on the use of proangiogenic growth factors to induce the growth of new blood vessels to …

Background. Therapeutic angiogenesis in ischemic myocardium has been shown to be a
feasible and effective strategy to improve regional blood flow and myocardial function. However…